SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-017092
Filing Date
2014-03-21
Accepted
2014-03-21 16:02:31
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v369493_10k.htm 10-K 1826342
2 EXHIBIT 10.16 v369493_ex10-16.htm EX-10.16 62927
3 EXHIBIT 10.17 v369493_ex10-17.htm EX-10.17 34276
4 EXHIBIT 10.18 v369493_ex10-18.htm EX-10.18 37442
5 EXHIBIT 31 v369493_ex31.htm EX-31 9771
6 EXHIBIT 32 v369493_ex32.htm EX-32 4082
13 GRAPHIC tes10-17logo.jpg GRAPHIC 19802
  Complete submission text file 0001144204-14-017092.txt   8946565

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lixt-20131231.xml EX-101.INS 1177514
8 XBRL TAXONOMY EXTENSION SCHEMA lixt-20131231.xsd EX-101.SCH 83981
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20131231_cal.xml EX-101.CAL 36067
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20131231_def.xml EX-101.DEF 305249
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20131231_lab.xml EX-101.LAB 435559
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20131231_pre.xml EX-101.PRE 355995
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 14710250
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences